COVID is not a flu. Not even a little. Here are reasons why:
1. It is a separate species. It is no more like influenza than you are like a hippo. DIFFERENT SPECIES.
2. It is an airborne virus. This means the tiny droplets can stay in the air for a full 2 hours. So if a person coughed in aisle 4 of Target 1.5 hours ago, they may be home now but their covid cloud is still hanging there just waiting for you to walk by and take a breath.Kind of like when someone in the bean aisle farts and walks away, the smell stays in the Mexican and tomatoes aisle when the guy is all the way over in frozen foods. But you go to pick up a can of kidney beans for tonight's chili, it hits you in the face like a fastball. Influenza is not an airborne virus. It is droplet spread- meaning someone has to directly crop dust you with their sneeze to get you sick. Covid is much more contagious.
3. Covid is more virulent. Virulence factor is a measure of how catchy something is. For example, the flu is like beer. It takes a bunch to get you drunk. Covid is more like tequila - A little goes a long way. You need to suck up a lot of flu particles to actually catch the flu; with covid, even a few particles is enough to infect you.
4. Covid has a longer incubation than the flu. When you catch the flu, you typically get sick in the next 1-2 days. This is awesome because it means you stay at home while contagious because you feel like a heap of fried garbage. Covid has a blissful 5-9 days of symptom free time during which you are well enough to head to the movies, gym or mar-a-lago while also being contagious enough to infect everyone you encounter.
5. Covid has a longer duration of illness than flu. With covid, you have a 5-9 days of blissful asymptomatic contagiousness. This then turns into about 1 week of cough and overall feeling like hell but still surviving. Week 2 is when things hit the fan and people end up unable to breathe and on a ventilator. Many stay on the vent for up to 15 days. 5 days incubating+7 kinda sick days + 15 days on a ventilator makes for 27 days of virus spreading illness, (assuming your don’t just die of massive asphyxiation and body-wide collapse from overwhelming infection somewhere in that last week). The flu has an average incubation of 1-2 days and sick time of 7 days for a total of 9 infectious days. In the world of deadly viruses, that 18 extra days might as well be a millennia.
6. Covid is more deadly. A LOT more deadly. The flu has about a 0.2% mortality rate, meaning 2 of every thousand people who get sick with flu will die. On the contrary, the death rate from covid is reportedly 2%, so 10 times more deadly than flu. Ten times more death seems like a lot more death to me. Whats more worrisome is that 2% is actually incorrect because it doesn’t usually kill kids so that skews the average. With covid, age is a major factor in survival. If we don’t include people under 30, the death rate for adults is on average 4.5%. 9 out of every 200 adults that get this will die from it. Do you know 200 adults? Do you think losing 9 of them is no big deal? Since mortality increases with age in covid, the risk gets worse as you get older so if we put 100 grannies in a room with covid, only 85 would make it out alive to make pies and tell great stories of the old days... and that just sucks.
I hope that helps to clarify why covid is in no way a flu, why you are in no way a hippo, and why staying home is the only way for non-essential people to do their part while I spend my days at work covered in a plastic poncho, sucking air through a stuffy respirator mask, leaving my scrubs in my driveway, showering the covid off at 4am when I get in, and thinking to myself “now do u still think it was just a flu?” as I risk my own life with my face 2 inches from their highly contagious, gasping mouth while I slide the plastic tube down their throat and start up the ventilator.
- Dr. Peter Tippett
More about Dr Tippett
https://en.wikipedia.org/wiki/Peter_Tippett
Peter Tippett (born 1953 in Dearborn, Michigan) is an American physician, researcher, and inventor known for contributions to information security, clinical medicine, and technology. These contributions include the development of the anti-virus program "Corporate Vaccine".[1] Tippett was Vice President of Verizon's Innovations Incubator and Chief Medical Officer for Verizon Enterprise Services from 2009 to 2015. He is currently the Founder and CEO of Healthcelerate Inc. [2]
Early life and education
Born in 1953 and raised in Dearborn, Michigan, Tippett is an alumnus of Kalamazoo College and holds both a Ph.D. and M.D. from Case Western Reserve University School of Medicine. He studied at the Rockefeller University in New York under Nobel Prize winner Robert Bruce Merrifield, directing his doctoral research efforts toward the metabolic indicators of peptide synthesis. He completed his internship and residency in Internal Medicine at Cleveland Metropolitan General Hospital, and spent 1975-1985 engaged in biochemical research.
Work history
While engaged in research at Case Western Reserve, Tippett moonlighted as an emergency room physician and instructor in Emergency and Outpatient Medicine, and spent much of his early clinical career (1989-1995) in Emergency Medicine in Ohio and California. He received his board certification in Internal Medicine in 1987. Between 1993 and 2000, he served on the board of the Computer Ethics Institute.[3]
He served as executive director of The Pacific Foundation for Science and Medicine from 1988 to 1992, an intersection of his clinical career with an emerging focus on technology, particularly in the arena of cybersecurity as well as the use and access protocols of the Internet. It was in his role as president and chairman of Certus International, a publisher and developer of PC anti-virus and security software, that Tippett applied his research insights as a biochemist to the concept of computer "viruses" to develop the anti-virus software, "Vaccine," which was later purchased by Symantec in 1992.[4] His CEO role with Cybertrust led to a merger of Cybertrust by Verizon and to Tippett's role in the Verizon healthcare and security innovations divisions. Tippett served as chairman of the Alliance for Internet Security in 2000.[5] He represented Verizon on the board of directors of The Open Identity Exchange (OIX)[6] and the Information Card Foundation.[7]
Technological achievements
In addition to being credited with development of one of the first anti-virus programs, "Vaccine", Tippett pioneered and commercialized a string of now-common technologies including what is now called the "Recovery Disk," processor image signatures, using hash-tables for trusted file execution and anomaly detection, aspects of mail merge and "un-do."[8] He ran a bulletin board system for CP/M software before the first IBM PC was created and was president of the Cleveland Osborne Group (a user group for the computers of the Osborne Computer Corporation) in the early 1980s.
As chief scientist for ICSA.net, Tippett was one of a handful of experts to identify and address[9] the ILOVEYOU virus that broke in May 2000[10] and provided key information to the Department of Justice about David Smith, the writer of the Melissa virus.[11] He was featured and on the cover of the August 2000 issue of Time Digital magazine.[12]
Professional activities
Tippett's work in the cybersecurity space has led to roles as speaker, contributor and advisor to government and private sector organizations. From 2003-2005,[13] he served on the President's Information Technology Committee (PITAC), established by Congress in 1997 under the High Performance Computing Act of 1991 to "guide the Administration's efforts to accelerate the development and adoption of information technologies vital for American prosperity in the 21st century."[14]
The U.S. Chamber of Commerce awarded Tippett its first Leadership in Health Care Award at the Chamber’s first annual Health Care Summit (2012) for his leadership of Verizon's incubator.[15] Tippett was also Chief Scientist for ICSA Labs and previously served as President of the International Computer Security Association.[16]
Tippett is currently an Adjunct Professor, Division of General Medical Sciences at Case Western Reserve University School of Medicine.[17]
In November 2017, T.E.N., a technology and information security executive networking and relationship-marketing firm, announced that Tippett was the recipient of the 2017 ISE® Luminary Leadership Award. [18]
Clinical publications
Tippett, P. S. (1975) Structural-Specificity Relationships of the Immunoglobulin Molecule and the Solid Phase Peptide Synthesis of two Antigen-binding Peptides. Archives of Kalamazoo College, Kalamazoo, MI.
Corporale, L. L H.; Tippett, P. S.; Erickson, B. W.; and Hugli, T. E. (1980) The Active Site of C3a Anaphylatoxin. J. Biol. Chem. 255 10758-10763.
Tippett, P. S. and Neet, K. E. (1982) Specific Inhibition of Glucokinase by Long Chain Acyl CoAs Belos the Critical Micelle Concentration. J. Biol. Chem. 257, 12839-12845.
Tippett, P. S. and Neet, K. E. (1982) An Allosteric Model for the Inhibition of Glucokinase by Long Chain Acyl CoA. J. Biol. Chem. 257, 12846-12852
Tippett, P. S. (1981) Kinetics and Regulation of Rat Liver Glucokinase (Ph.D.). University Microfilms International, Ann Arbor, Mi.
Tippett, P. S. and Neet, K. E. (1983) Interconversion Between Different Sulfhydryl-Related Kinetic States in Glucokinase. Arch. Biochem. Biophys. 222, 285-289.
Powell, G. L.; Tippett, P. S.; et al. (1985) Fatty acyl-CoA as an Effector Molecule in Metabolism. Federation Proceedings 44, 81-84.
Neet, K. E.; Tippett, P. S.; and Keenan, R. P. (1986) Regulatory Properties of Glucokinase, Regulation and Metabolism. Wiley, London.
Tippett, P. S. (1986) Regulation of Enzymes by Long Chain Acyl CoAs, Fact or Fantasy. Trends in Biochemical Sciences, 11.